We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 245

DOJ and FTC Propose Updated Antitrust Guidelines for Licensing of Intellectual Property
  • Hogan Lovells
  • USA
  • August 17 2016

On August 12, the U.S. Department of Justice Antitrust Division (DOJ) and Federal Trade Commission (FTC) proposed updates to their Antitrust


Antitrust lawsuit shows DOJ support of steering transparency initiatives
  • Hogan Lovells
  • USA
  • July 14 2016

Antitrust agencies have made it clear that hospital mergers are a high enforcement priority. United States v Carolinas Healthcare System signals that


Antitrust Lawsuit Against Carolinas Healthcare System Shows DOJ Support of Steering, Transparency Initiatives
  • Hogan Lovells
  • USA
  • June 24 2016

The antitrust agencies have made it clear that hospital mergers are a high enforcement priority. A new lawsuit, United States v. Carolinas Healthcare


Information exchanges: a new frontier in antitrust enforcement
  • Hogan Lovells
  • European Union, USA
  • April 28 2016

The treatment of exchanges of competitively sensitive information among competitors represents a new frontier in antitrust enforcement because the


State boards seeking an antitrust pass? FTC explains what they need to know
  • Hogan Lovells
  • USA
  • November 19 2015

A February 2015 Supreme Court decision held that state regulatory boards run by "a controlling number" of "active market participants" can qualify


FTC ALJ: embarrassmentemotional harm and risk of harm does not satisfy “substantial consumer injury” prong of unfairness
  • Hogan Lovells
  • USA
  • November 17 2015

On November 13, 2015, the Federal Trade Commission’s (FTC) Chief Administrative Law Judge (ALJ) dismissed an FTC administrative complaint based on


Department of Justice delivers roadmap to compliance credit in cartel cases
  • Hogan Lovells
  • USA
  • November 12 2015

For only the second time the Antitrust Division of the Department of Justice has recommended that a corporate defendant receive a fine reduction for


Price discrimination in the pharmaceutical sector: new decision, but plaintiffs face same challenges
  • Hogan Lovells
  • USA
  • October 28 2015

The Second Circuit recently affirmed a lower court ruling dismissing claims brought by retail pharmacies against Johnson & Johnson, Caremark, Express


State boards seeking an antitrust pass? FTC explains what they need to know
  • Hogan Lovells
  • USA
  • October 21 2015

A Supreme Court decision from February ruled that state regulatory boards run by "a controlling number" of "active market participants" can qualify


DOJ calls for pursuit of executives in corporate investigations
  • Hogan Lovells
  • USA
  • October 19 2015

On September 9 2015 the US Department of Justice (DOJ) formally announced a policy that is consistent with shifting trends in prosecution: the DOJ